secwatch / observer

Shareholder Votes

Results of shareholder votes disclosed under 8-K Item 5.07.

8-K items 5.07 JSON
RENX RenX Enterprises Corp.

RenX Enterprises Corp. shareholders approved Approval of Adjournment of Annual Meeting.

“Proposal 8– Adjournment Proposal The stockholders approved an adjournment of the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Additional February Warrant Exercise Proposal, the Initial April Note and Second April Note Conversion Proposal, the Additional April Note Conversion Proposal, the Reverse Stock Split Proposal or the 2023 Plan Amendment Proposal, based on the votes below. However, the Company elected not to adjourn the Annual Meeting, as such an adjournment was not necessary in light of the approval of the Additional February Warrant Exercise Proposal, the Initial April Note and Second April Note Conversion Proposal, the Additional April Note Conversion Proposal, the Reverse Stock Split Proposal and the 2023 Plan Amendment Proposal at the Annual Meeting. For Against Abstain Broker Non-Votes 803,648 179,085 16,546 0”
RENX RenX Enterprises Corp.

RenX Enterprises Corp. shareholders approved Approval of Amendment to 2023 Plan.

“Proposal 7 – 2023 Plan Amendment Proposal The stockholders approved an amendment to the Company’s 2023 Plan to (i) increase the number of shares of Common Stock authorized for issuance under the 2023 Plan from 138,861 shares to 520,000 shares, and (ii) increase the total number of shares of Common Stock with respect to which awards may be granted to any non-employee director in his or her capacity as a non-employee director in any single calendar year by 72,500 shares to 75,000 shares, based on the votes below: For Against Abstain Broker Non-Votes 541,578 28,484 1,939 427,279”
RENX RenX Enterprises Corp.

RenX Enterprises Corp. shareholders approved Approval of Reverse Stock Split.

“Proposal 6 - Reverse Stock Split Proposal The stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to, at the discretion of the Board, effect a reverse stock split with respect to the Company’s issued and outstanding Common Stock, at a ratio of 1-for-5 to 1-for-10 (the “Range”), with the final ratio within such Range to be determined at the discretion of the Board and included in a public announcement, based on the votes below: For Against Abstain Broker Non-Votes 801,362 193,585 4,333 0”
RENX RenX Enterprises Corp.

RenX Enterprises Corp. shareholders approved Approval of Additional April Note Conversion.

“Proposal 5 – Additional April Note Conversion Proposal The stockholders approved, pursuant to Nasdaq Rule 5635(d), of the issuance of up to an additional 179,213,485 shares of the Company’s Common Stock upon the conversion of additional April Notes in the aggregate principal amount of up to $87.0 million (collectively, the “Additional April Notes”) (assuming such Additional April Notes accrue interest at 10% for 12 months and that the conversion price is reduced to the floor price), which Additional April Notes may in the future be issued to investors pursuant to the April Purchase Agreement, based on the votes below: For Against Abstain Broker Non-Votes 539,231 30,318 2,452 427,279”
RENX RenX Enterprises Corp.

RenX Enterprises Corp. shareholders approved Approval of Initial April Note and Second April Note Conversion.

“Proposal 4 — Initial April Note and Second April Note Conversion Proposal The stockholders approved, pursuant to Nasdaq Rule 5635(d), of the issuance of up to 26,779,029 shares of the Company’s Common Stock upon the conversion of senior convertible notes (collectively, the “April Notes”) in the aggregate principal amount of up to $13.0 million (assuming such April Notes accrue interest at 10% for 12 months and that the conversion price is reduced to the floor price), which April Notes have been, or may in the future be, issued to investors pursuant to a Securities Purchase Agreement dated April 30, 2026 (the “April Purchase Agreement”), based on the votes below: For Against Abstain Broker Non-Votes 542,888 26,661 2,452 427,279”
RENX RenX Enterprises Corp.

RenX Enterprises Corp. shareholders approved Approval of Additional February Warrant Exercise at the 2026-02-17 meeting.

“Proposal 3 — Additional February Warrant Exercise Proposal The stockholders approved, pursuant to Nasdaq Rule 5635(d), the issuance of up to 862,335 shares of the Company’s Common Stock upon the exercise of certain warrants which were issued to investors in connection with the Company’s private placement offering that closed on February 17, 2026, based on the votes listed below: Votes For Votes Against Abstentions Broker Non-Votes 546,161 22,436 3,404 427,279”
RENX RenX Enterprises Corp.

RenX Enterprises Corp. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-12-31 meeting.

“Proposal 2 — Auditor Ratification Proposal The stockholders ratified the appointment of M&K CPAS PLLC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, based on the votes below: Votes For Votes Against Abstentions Broker Non-Votes 837,316 152,570 9,393 -”
RENX RenX Enterprises Corp.

RenX Enterprises Corp. shareholders approved Election of Class III Directors.

“Proposal 1 — Election of Class III Directors Proposal The stockholders elected each of James D. Burnham and Peter G. DeMaria to serve as a Class III director until the 2029 Annual Meeting of Stockholders, based on the votes below: For Withheld Broker Non-Votes James D. Burnham 556,017 15,984 427,279 Peter G. DeMaria 555,947 16,054 427,279”
JBI Janus International Group, Inc.

Janus International Group, Inc. shareholders approved Advisory vote on the compensation of the named executive officers at the 2026-06-15 meeting.

“Proposal 3 - Compensation of Named Executive Officers: For Against Abstain Broker Non-Votes 109,765,147 7,873,768 662,490 12,012,157”
JBI Janus International Group, Inc.

Janus International Group, Inc. shareholders approved Ratification of KPMG LLP as the independent registered public accounting firm for the year ending January 2, 2027 at the 2026-06-15 meeting.

“Proposal 2 - Ratification of KPMG LLP as the Independent Registered Public Accounting Firm: For Against Abstain Broker Non-Votes 130,252,524 60,862 176 –”
JBI Janus International Group, Inc.

Janus International Group, Inc. shareholders approved Election of three nominees (Paul Vasington, Jeannine Lane, and Eileen M. Youds) to serve as Class II directors for a two-year term at the 2026-06-15 meeting.

“Proposal 1 - Election of Class II Directors: For Withhold Broker Non-Votes Paul Vasington 118,090,427 210,978 12,012,157 Jeannine Lane 117,092,960 1,208,445 12,012,157 Eileen M. Youds 114,964,599 3,336,806 12,012,157”
APT ALPHA PRO TECH LTD

ALPHA PRO TECH LTD shareholders approved Advisory Approval of Executive Compensation at the 2026-06-10 meeting.

“Proposal 3 – Advisory Approval of Executive Compensation . The shareholders adopted a resolution approving, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission. The result of the vote taken at the Annual Meeting was as follows: Votes For Votes Against Abstain Broker Non-Votes 3,500,455 1,119,354 44,820 2,324,063”
APT ALPHA PRO TECH LTD

ALPHA PRO TECH LTD shareholders approved Ratification of the Appointment of Tanner LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026 at the 2026-06-10 meeting.

“Proposal 2 – Ratification of the Appointment of Tanner LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026 . The shareholders ratified the appointment of Tanner LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The result of the vote taken at the Annual Meeting was as follows: Votes For Votes Against Abstain 6,643,578 329,264 15,849”
APT ALPHA PRO TECH LTD

ALPHA PRO TECH LTD shareholders approved Election of Directors at the 2026-06-10 meeting.

“Proposal 1 – Election of Directors . The shareholders elected each of the director nominees to serve as directors during the ensuing year. The voting for the directors at the Annual Meeting was as follows: Name Votes For Withhold Authority Broker Non-Votes James Buchan 4,478,859 185,771 2,324,062 David R. Garcia 4,513,043 151,587 2,324,062 Lloyd Hoffman 4,524,627 140,003 2,324,062 Donna Millar 4,464,536 200,094 2,324,062 Danny Montgomery 4,475,583 189,047 2,324,062 John Ritota 4,200,457 464,173 2,324,062 Benjamin A. Shaw 4,602,341 62,289 2,324,062”
APPF APPFOLIO INC

APPFOLIO INC shareholders approved Advisory Vote on Named Executive Officer Compensation at the 2026-06-12 meeting.

“Proposal 3 – Advisory Vote on Named Executive Officer Compensation The third proposal voted upon at the Annual Meeting was the approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. At the Annual Meeting, the proposal was approved by the following vote: For Against Abstain Broker Non-Votes 130,615,480 546,022 18,346 2,013,745”
APPF APPFOLIO INC

APPFOLIO INC shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-12 meeting.

“Proposal 2 – Ratification of Appointment of Independent Registered Public Accounting Firm The second proposal voted upon at the Annual Meeting was the ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. At the Annual Meeting, the proposal was approved by the following vote: For Against Abstain Broker Non-Votes 133,132,040 52,759 8,794 —”
APPF APPFOLIO INC

APPFOLIO INC shareholders approved Election of Class II Directors at the 2026-06-12 meeting.

“Proposal 1 – Election of Class II Directors The first proposal voted upon at the Annual Meeting was the election of two Class II directors, Olivia Nottebohm and Saori Casey, to a three-year term to hold office until the Company’s 2029 Annual Meeting of Stockholders, and until the date on which their respective successors are duly elected and qualified. At the Annual Meeting, the Class II directors were elected by the following votes: Name of Director For Withheld Broker Non-Votes Olivia Nottebohm 125,033,431 6,146,417 2,013,745 Saori Casey 130,956,960 222,888 2,013,745”
MGTX MeiraGTx Holdings plc

MeiraGTx Holdings plc shareholders approved Ratification, by ordinary resolution, of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“Item 2 – Ratification, by ordinary resolution, of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. ​ FOR ​ ​ ​ AGAINST ​ ​ ​ ABSTAINED 73,933,288 ​ 1,029,075 ​ 363,659”
MGTX MeiraGTx Holdings plc

MeiraGTx Holdings plc shareholders approved Election of three Class II directors to hold office until the Company's annual general meeting of shareholders to be held in 2029 and until their respective successors have been duly elected and qualified at the 2026-06-11 meeting.

“Item 1 – Election of three Class II directors to hold office until the Company’s annual general meeting of shareholders to be held in 2029 and until their respective successors have been duly elected and qualified. ​ ​ ​ ​ ​ ​ FOR ​ ​ ​ WITHHELD ​ ​ ​ BROKER NON-VOTES Ellen Hukkelhoven, Ph.D ​ 63,644,550 ​ 246,847 ​ 11,434,625 Nicole Seligman ​ 62,881,518 ​ 1,009,879 ​ 11,434.625 Debra Yu, M.D. ​ 54,192,550 ​ 9,698,847 ​ 11,434,625”
TOST Toast, Inc.

Toast, Inc. shareholders approved Advisory vote on compensation of named executive officers for fiscal year ended December 31, 2025 at the 2026-06-12 meeting.

“The Company’s stockholders approved, on an advisory, non-binding basis, the compensation of the Company’s named executive officers for the fiscal year ended December 31, 2025, as disclosed in the Company’s proxy statement for the Annual Meeting pursuant to the compensation disclosure rules of the SEC.”
TOST Toast, Inc.

Toast, Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-12 meeting.

“The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”
TOST Toast, Inc.

Toast, Inc. shareholders approved Election of Class II directors at the 2026-06-12 meeting.

“The Company’s stockholders elected each of Kent Bennett, Susan Chapman-Hughes and Mark Hawkins as a Class II director of the Company’s board of directors for a three-year term expiring at the Company’s 2029 Annual Meeting of Stockholders and until such director’s respective successor is duly elected and qualified, or such director’s earlier death, resignation or removal.”
BETA BETA Technologies, Inc.

BETA Technologies, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-11 meeting.

“Proposal 2 - Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The voting results were as follows: Votes FOR Votes AGAINST Votes ABSTAINED 456,808,256 85,288 69,390”
BETA BETA Technologies, Inc.

BETA Technologies, Inc. shareholders approved Election of Class I Directors at the 2026-06-11 meeting.

“Proposal 1 - Election of Class I Directors The stockholders elected the individuals listed below as Class I directors to serve on the Company’s Board of Directors for a three-year term expiring in 2029. The voting results were as follows: Nominee Votes FOR Votes WITHHELD Broker Non-Votes John Abele 442,815,464 8,546,325 5,601,145 James McConville 445,363,685 5,998,104 5,601,145 John Slattery 445,059,775 6,302,014 5,601,145”
RIOT Riot Platforms, Inc.

Riot Platforms, Inc. shareholders approved Approval of the Seventh Amendment to the 2019 Equity Plan to Increase the Number of Shares Reserved for Issuance thereunder by 15,000,000 Shares at the 2026-06-15 meeting.

“Proposal No. 4: Approval of the Seventh Amendment to the 2019 Equity Plan to Increase the Number of Shares Reserved for Issuance thereunder by 15,000,000 Shares For ​ ​ ​ Against ​ ​ ​ Abstaining ​ ​ ​ Broker Non-Votes ​ ​ ​ ​ ​ ​ ​ ​ 210,658,327 ​ 4,308,923 ​ 871,839 ​ 55,950,688”
RIOT Riot Platforms, Inc.

Riot Platforms, Inc. shareholders approved Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers at the 2026-06-15 meeting.

“Proposal No. 3: ​ ​ Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers For ​ ​ ​ Against ​ ​ ​ Abstaining ​ ​ ​ Broker Non-Votes ​ ​ ​ ​ ​ ​ ​ ​ 210,538,101 ​ 4,343,765 ​ 957,223 ​ 55,950,688”
RIOT Riot Platforms, Inc.

Riot Platforms, Inc. shareholders approved Ratification, in a Non-binding Advisory Basis, of Auditor Appointment at the 2026-06-15 meeting.

“Proposal No. 2: ​ ​ Ratification, in a Non-binding Advisory Basis, of Auditor Appointment For ​ ​ ​ Against ​ ​ ​ Abstaining ​ ​ ​ Broker Non-Votes ​ ​ ​ ​ ​ ​ ​ ​ 270,339,887 ​ 810,653 ​ 639,237 ​ 0”
RIOT Riot Platforms, Inc.

Riot Platforms, Inc. shareholders approved Election of Directors at the 2026-06-15 meeting.

“Proposal No. 1: ​ ​ Election of Directors Director Nominee ​ ​ ​ Director Class ​ ​ ​ Expiration of Term ​ ​ ​ For ​ ​ ​ Withheld ​ ​ ​ Broker Non-Votes Lance D’Ambrosio ​ Class II ​ 2029 Annual Meeting ​ 193,555,099 ​ 22,283,990 ​ 55,950,688 ​ Michael Turner ​ Class II ​ 2029 Annual Meeting ​ 203,597,300 ​ 12,241,789 ​ 55,950,688”
BCG Binah Capital Group, Inc.

Binah Capital Group, Inc. shareholders approved Approval of amendment to 2024 Equity Incentive Plan to increase authorized shares at the 2026-06-12 meeting.

“Proposal 5 : This proposal was approved with 10,900,419 “FOR” votes, 690,509 “AGAINST” votes and 431 “ABSTAIN” votes. There were 1,153,475 broker non-votes in connection with this proposal.”
BCG Binah Capital Group, Inc.

Binah Capital Group, Inc. shareholders approved Ratification of appointment of FGMK, LLC as independent auditor at the 2026-06-12 meeting.

“Proposal 4 : This proposal was approved with 12,652,706 “FOR” votes, 90,812 “AGAINST” votes and 1,316 “ABSTAIN” votes.”
BCG Binah Capital Group, Inc.

Binah Capital Group, Inc. shareholders approved Advisory vote on frequency of future say-on-pay votes at the 2026-06-12 meeting.

“Proposal 3 : The stockholders approved, on a non-binding advisory basis, a frequency of “every one year” for future advisory votes on executive compensation. The voting results were as follows: 11,576,606 votes for “ONE YEAR,” 7,472 votes for “TWO YEARS,” 6,222 votes for “THREE YEARS” and 1,059 “ABSTAIN” votes. There were 1,153,475 broker non-votes in connection with this proposal.”
BCG Binah Capital Group, Inc.

Binah Capital Group, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-12 meeting.

“Proposal 2 : This proposal was approved with 11,530,512 “FOR” votes, 55,126 “AGAINST” votes and 5,721 “ABSTAIN” votes. There were 1,153,475 broker non-votes in connection with this proposal.”
BCG Binah Capital Group, Inc.

Binah Capital Group, Inc. shareholders approved Election of Class II director Daniel Hynes at the 2026-06-12 meeting.

“Proposal 1 : The voting results for the election of the director nominee were as follows: For Withheld Broker Non-Vote Daniel Hynes 11,537,532 53,827 1,153,475”
QURE uniQure N.V.

uniQure N.V. shareholders approved Resolution to adopt the amendment to the Company’s Articles of Association to include a federal forum selection provision at the 2026-06-10 meeting.

“Proposal 15 - Resolution to adopt the amendment to the Company’s Articles of Association to include a federal forum selection provision. This proposal was approved as set forth below. For Against Abstain Broker Non-Votes 33,960,143 3,880,065 69,211 6,613,632”
QURE uniQure N.V.

uniQure N.V. shareholders approved Resolution to adopt the amendment to the Company’s Articles of Association to increase the authorized share capital and number of ordinary shares at the 2026-06-10 meeting.

“Proposal 14 - Resolution to adopt the amendment to the Company’s Articles of Association to increase the authorized share capital and number of ordinary shares. This proposal was approved as set forth below. For Against Abstain Broker Non-Votes 37,616,838 265,504 27,077 6,613,632”
QURE uniQure N.V.

uniQure N.V. shareholders approved Resolution to adopt the amendment to the Company’s Articles of Association to reflect Dutch large company regime at the 2026-06-10 meeting.

“Proposal 13 - Resolution to adopt the amendment to the Company’s Articles of Association to reflect Dutch large company regime. This proposal was approved as set forth below. For Against Abstain Broker Non-Votes 28,197,514 9,657,289 54,616 6,613,632”
QURE uniQure N.V.

uniQure N.V. shareholders approved Resolution to adopt the Plan Amendment and authorize the Board to issue ordinary shares and grant rights to subscribe for ordinary shares pursuant to the 2014 Plan (as amended by the Plan Amendment) at the 2026-06-10 meeting.

“Proposal 12 - Resolution to adopt the Plan Amendment and authorize the Board to issue ordinary shares and grant rights to subscribe for ordinary shares pursuant to the 2014 Plan (as amended by the Plan Amendment). This proposal was approved as set forth below. For Against Abstain Broker Non-Votes 37,461,945 389,128 58,346 6,613,632”
QURE uniQure N.V.

uniQure N.V. shareholders approved Approval, on an advisory basis, of the frequency of advisory votes on the compensation of the named executive officers of the Company at the 2026-06-10 meeting.

“Proposal 11 - Approval, on an advisory basis, of the frequency of advisory votes on the compensation of the named executive officers of the Company. The results of the advisory vote are set forth below. 1 Year 2 Years 3 Years Abstain Broker Non-Votes 37,197,949 47,246 628,681 35,543 6,613,632”
QURE uniQure N.V.

uniQure N.V. shareholders approved Approval, on an advisory basis, the compensation of the named executive officers of the Company at the 2026-06-10 meeting.

“Proposal 10 - Approval, on an advisory basis, the compensation of the named executive officers of the Company. This proposal was approved as set forth below. For Against Abstain Broker Non-Votes 37,422,626 414,084 72,709 6,613,632”
QURE uniQure N.V.

uniQure N.V. shareholders approved Appointment KPMG Accountants N.V. as external auditors of the Company for the fiscal year 2026 at the 2026-06-10 meeting.

“Proposal 9 - Appointment KPMG Accountants N.V. as external auditors of the Company for the fiscal year 2026. This proposal was approved as set forth below. For Against Abstain Broker Non-Votes 44,419,027 82,473 21,551 0”
QURE uniQure N.V.

uniQure N.V. shareholders approved Reappointment of Leonard Post as non-executive director at the 2026-06-10 meeting.

“Proposal 5 - Reappointment of Leonard Post as non-executive director. This proposal was approved as set forth below. For Against Abstain Broker Non-Votes 37,326,031 550,517 32,871 6,613,632”
QURE uniQure N.V.

uniQure N.V. shareholders approved Reappointment of Jack Kaye as non-executive director at the 2026-06-10 meeting.

“Proposal 4 - Reappointment of Jack Kaye as non-executive director. This proposal was approved as set forth below. For Against Abstain Broker Non-Votes 37,256,535 619,247 33,637 6,613,632”
QURE uniQure N.V.

uniQure N.V. shareholders approved Reappointment of Madhavan Balachandran as non-executive director at the 2026-06-10 meeting.

“Proposal 3 - Reappointment of Madhavan Balachandran as non-executive director. This proposal was approved as set forth below. For Against Abstain Broker Non-Votes 37,342,223 533,759 33,437 6,613,632”
BJRI BJs RESTAURANTS INC

BJs RESTAURANTS INC shareholders approved Ratification of Appointment of KPMG LLP as Independent Registered Public Accounting Firm for Fiscal 2026 at the 2026-06-11 meeting.

“Ratification of Accountants . The shareholders approved the ratification of KPMG LLP as our independent registered public accounting firm for the 2026 fiscal year. The following votes were cast on the ratification: 20,149,784 For; 2,486 Against; 5,933 Abstain. There were no broker non-votes.”
BJRI BJs RESTAURANTS INC

BJs RESTAURANTS INC shareholders approved Advisory Vote on Executive Compensation at the 2026-06-11 meeting.

“Advisory Vote on Executive Compensation . The shareholders approved, on an advisory and non-binding basis, the compensation of named executive officers. The following votes were cast on the compensation of named executive officers: 17,475,034 For; 110,111 Against; 9,765 Abstain. There were 2,563,293 broker non-votes.”
BJRI BJs RESTAURANTS INC

BJs RESTAURANTS INC shareholders approved Election of Directors at the 2026-06-11 meeting.

“Election of Directors . Each of the following nominees for director was elected to serve until the next annual meeting of shareholders or until his or her successor is elected and qualified. Name For Withhold Broker Non-Votes Bina Chaurasia 17,473,110 121,800 2,563,293 James A. Dal Pozzo 16,899,501 695,409 2,563,293 Noah A. Elbogen 17,307,936 286,974 2,563,293 Lea Anne S. Ottinger 16,907,566 687,344 2,563,293 C. Bradford Richmond 17,559,900 35,010 2,563,293 Julius W. Robinson, Jr. 17,568,177 26,733 2,563,293 Janet M. Sherlock 17,333,955 260,955 2,563,293 Lyle D. Tick 17,468,494 126,416 2,563,293”
HCWB HCW Biologics Inc.

HCW Biologics Inc. shareholders approved Approval of repricing of Existing Warrants under Nasdaq Listing Rule 5635(d) at the 2026-06-15 meeting.

“5. The Company’s stockholders approved, for purposes of complying with Nasdaq Listing Rule 5635(d), the repricing of certain warrants issued on November 20, 2025 to purchase up to 3,020,410 shares of our Common Stock pursuant to that certain Existing Warrants Amendment Agreement, dated February 17, 2026, to reduce the exercise price of the Existing Warrants to $0.6055 per share, and to approve the issuance of shares of our Common Stock upon exercise of the Existing Warrants as so amended. For Against Abstain Broker Non-Votes 1,083,864 251,605 23,095 1,189,957”
HCWB HCW Biologics Inc.

HCW Biologics Inc. shareholders approved Approval of issuance of shares upon exercise of Common Warrants under Nasdaq Listing Rule 5635(d) at the 2026-06-15 meeting.

“4. The Company’s stockholders approved, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of our Common Stock upon exercise of up to 2,477,292 Common Stock Purchase Warrants (the “Common Warrants”) issued pursuant to that certain Securities Purchase Agreement, dated February 17, 2026, entered into in connection with the Company’s follow-on public offering of Units, consisting of one share of Common Stock purchased for $0.6055 and one Common Warrant which may be exercised to purchase one share of Common Stock for $0.6055 per share.. For Against Abstain Broker Non-Votes 1,102,910 233,136 22,518 1,189,957”
HCWB HCW Biologics Inc.

HCW Biologics Inc. shareholders approved Approval of amendment to certificate of incorporation to implement one or more reverse stock splits at the 2026-06-15 meeting.

“3. The Company’s stockholders approved an amendment to the Company’s certificate of incorporation on or before the one (1) year anniversary of the Annual Meeting, to implement one or more reverse stock splits of the outstanding shares of the Company’s common stock, par value $0.0001 per share (our “Common Stock”) (as necessary to maintain a listing of our Common Stock on The Nasdaq Stock Market LLC (“Nasdaq”)) in an aggregate range from one-for-five (1:5) up to one-for-twenty (1:20). For Against Abstain Broker Non-Votes 2,231,771 258,125 58,625 —”
HCWB HCW Biologics Inc.

HCW Biologics Inc. shareholders approved Ratification of Crowe LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-06-15 meeting.

“2. The Company’s stockholders ratified the appointment of Crowe LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. For Against Abstain Broker Non-Votes 2,536,919 1,748 9,854 —”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.